[Elastase and alpha-1 proteinase inhibitor complex in broncho-alveolar lavage fluid in patients with bronchial asthma and sarcoidosis]

Pol Merkur Lekarski. 2003 May;14(83):397-9.
[Article in Polish]

Abstract

Forty-three patients were enrolled into this study, twenty-eight with sarcoidosis in various radiological stages (I, II, III) and activity of disease (active or non-active) and fifteen with bronchial asthma. Elastase and alpha 1-proteinase inhibitor complex (E-alpha 1IP) concentrations and percentage of neutrophils in broncho-alveolar lavage fluid (BALF) were measured in all groups of patients. There were no significant differences in E-alpha 1IP levels in patients with various activity of sarcoidosis. We noticed significant differences between radiological stages of sarcoidosis. E-alpha 1IP concentration in the pulmonary stage was significantly higher than in stage I hilar adenopathy and stage II hilar adenopathy plus pulmonary opacities. E-alpha 1IP concentrations in BALF were significantly higher in patients with bronchial asthma in comparison to patients with sarcoidosis.

Publication types

  • English Abstract

MeSH terms

  • Adult
  • Asthma / drug therapy
  • Asthma / therapy*
  • Bronchial Diseases / drug therapy
  • Bronchial Diseases / therapy*
  • Bronchoalveolar Lavage / methods*
  • Drug Therapy, Combination
  • Female
  • Humans
  • Male
  • Protease Inhibitors / therapeutic use*
  • Proteinase Inhibitory Proteins, Secretory
  • Proteins / therapeutic use*
  • Sarcoidosis / drug therapy
  • Sarcoidosis / therapy*

Substances

  • Protease Inhibitors
  • Proteinase Inhibitory Proteins, Secretory
  • Proteins